Polibeli Group Ltd Class A Ordinary Shares (PLBL) had the highest return on July 2 by a mid-cap US stock, returning 14%.

ASSET	DATE	% RETURN
Polibeli Group Ltd Class A Ordinary Shares (PLBL)	7/2/2026	14%
Sellas Life Sciences (SLS)	7/2/2026	13.48%
Avis Budget (CAR)	7/2/2026	9.85%
Immunome (IMNM)	7/2/2026	9.31%
Youdao (DAO)	7/2/2026	9%
Navan, Inc Class A Common Stock (NAVN)	7/2/2026	8.73%
Tarsus Pharmaceuticals (TARS)	7/2/2026	8.25%
First Advantage (FA)	7/2/2026	7.6%
Sunshine Silver Mining & Refining (SSMR)	7/2/2026	6.96%
Crispr Therapeutics (CRSP)	7/2/2026	6.94%
Parabilis Medicines, Inc Common Stock (PBLS)	7/2/2026	6.25%
Slide Insurance Holdings, Inc Common Stock (SLDE)	7/2/2026	6.25%
Molson Coors Beverage (TAP.A)	7/2/2026	6.22%
Accelerant (ARX)	7/2/2026	6.17%
AeroVironment (AVAV)	7/2/2026	5.9%
Iovance Biotherapeutics (IOVA)	7/2/2026	5.9%
Abcellera Biologics (ABCL)	7/2/2026	5.87%
Precigen (PGEN)	7/2/2026	5.82%
ServiceTitan, Inc Class A Common Stock (TTAN)	7/2/2026	5.72%
Paymentus (PAY)	7/2/2026	5.58%
Monday (MNDY)	7/2/2026	5.57%
AtriCure (ATRC)	7/2/2026	5.3%
Dyne Therapeutics (DYN)	7/2/2026	5.25%
Science Applications International Corporation Common Stock (SAIC)	7/2/2026	5.21%
West Fraser Timber (WFG)	7/2/2026	5.2%

Mid-cap stocks are treated as having a market cap between $2B and $10B.